New drug could stop onslaught of juvenile diabetes
Unlike Type 2, Type 1 diabetes not linked to obesity or poor diet
British scientists are testing a drug that could stop children from developing diabetes. Youngsters could conceivably be screened for vulnerability at school, and then given the drug to keep them healthy. Charities said the pioneering work could bring us a "step closer to a world without diabetes."
Unlike Type 2 diabetes, which is also on the rise, childhood diabetes is not linked to poor diet and obesity.
The condition is caused when the immune system kills cells in the pancreas which make insulin, the hormone which converts sugar into energy. Diabetes can take 20 years off the average person's lifespan -- and the number of sufferers is soaring worldwide.
Unlike Type 2 diabetes, which is also on the rise, it is not linked to poor diet and obesity.
The new drug tries to bring the immune system back under control by boosting numbers of a second, protective type of immune cell. Developed at King's College London and Cardiff University, a drug trial is now under way, 24 diabetics will be given vaccination-type injections every two weeks for six months.
An earlier trial found the drug to be safe and to produce "encouraging" changes in the immune system.
"With prevention there is everything to play for," King's researcher Mark Peakman says. Another option would be to slow or delay progression of the condition in those who have recently been diagnosed.
Much more research is needed, meaning the treatment is five to ten years away from widespread use.
Scientists say that the treatment is not expected to help those who have had the condition for years and will be of no benefit to those with Type 2 diabetes.
"We are facing something of an epidemic of Type 1 diabetes," Professor Peakman, who is collaborating with Colin Dayan, of Cardiff University says.
"Once you have it as a child, you have got it for life and it leads to complications and obviously it is not a very nice thing to live with." Peakman added that more volunteers are needed for the trial, between the ages of 18 and 40 and have recently been diagnosed with the condition.
"If this drug works, it would mean that there will be a future generation for whom Type 1 diabetes is no longer a risk," Sarah Johnson, of the Juvenile Diabetes Research Foundation, which is part funding the study says.
"But it is early days. This is not something that is going to happen tomorrow."
© 2013, Distributed by NEWS CONSORTIUM.
Pope Francis Prayer Intentions for December 2013
General Intention: Victimized Children. That children who are victims of abandonment or violence may find the love and protection they need.
Missionary Intention: Prepare the Savior's Coming. That Christians, enlightened by the Word incarnate, may prepare humanity for the Savior's coming.
Rate This Article
Leave a Comment
More Health News
- Donors from around the world say that an AIDS-free generation may be within sight
- Washington signing up more people for Medicaid than private plans
- Man documents ravages of diabetes to his feet as they decay within 10 DAYS
- Dementia epidemic only growing worse: 135 million sufferers could arrive by 2050
- Men are from Mars, Women from Venus? Their brains are certainly wired differently
- Drinking water from plastic cups, bottles may be causing migraine headaches
- Apocalypse imminent as bacteria evolve beyond antibiotics
- New injection gives arthritics new hope
- Overweight people need to curb blood pressure to cut heart attack risk, doctors say
- Fr. Paul Schenck: Finding Living Faith on Catechetical Sunday
- The Movie Yellow: Incest as 'Normal' and Cassavates's Slides Into the World of Woes
- The Chicago School Teachers Strike Reveals the Need For School Choice
- The Sexual Barbarians and the Dissolution of Culture
- The Happy Priest Challenges Us to Ask: Who is Jesus to Me?
- Michael Coren on Canadian Public Schools: Teachers, leave those kids alone
- We Cannot Ignore Our Consciences: Cardinal Dolan On Religious Liberty
- In the Face of Danger, Successor of Peter Travels to Lebanon as a Messenger of Peace
- Reflections on the Dignity and Vocation of Women: Who or What?